Ezetimibe and Simvastatin (Impax Generics)
Welcome to the PulseAid listing for the Ezetimibe and Simvastatin drug offered from Impax Generics. This Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Impax Generics |
| NON-PROPRIETARY NAME: | EZETIMIBE and SIMVASTATIN |
| SUBSTANCE NAME: | EZETIMIBE; SIMVASTATIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Decreased Cholesterol Absorption [PE],Dietary Cholesterol Absorption Inhibitor [EPC],HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-04-26 |
| END MARKETING DATE: | 0000-00-00 |
Ezetimibe and Simvastatin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ezetimibe and Simvastatin from Impax Generics |
| LABELER NAME: | Impax Generics |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10; 10(mg/1; mg/1) |
| START MARKETING DATE: | 2017-04-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0115-1385_60aaefd2-4174-400d-b73a-a724eae43a78 |
| PRODUCT NDC: | 0115-1385 |
| APPLICATION NUMBER: | ANDA201890 |
Other EZETIMIBE; SIMVASTATIN Pharmaceutical Manufacturers / Labelers:
